Dually targeted bioinspired nanovesicle delays advanced prostate cancer tumour growth in vivo.

Ma, Guanglong; Severic, Maja; Barker, Matthew; Pereira, Sara; Ruiz, Amalia; Cheung, Calvin C L; Al-Jamal, Wafa T

Ma, Guanglong; Severic, Maja; Barker, Matthew; Pereira, Sara; Ruiz, Amalia; Cheung, Calvin C L; Al-Jamal, Wafa T.

Afiliación

Ma G; School of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, United Kingdom.
Severic M; School of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, United Kingdom.
Barker M; School of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, United Kingdom.
Pereira S; School of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, United Kingdom.
Ruiz A; School of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, United Kingdom.
Cheung CCL; School of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, United Kingdom.
Al-Jamal WT; School of Pharmacy, Queen's University Belfast, Belfast, BT9 7BL, United Kingdom. Electronic address: w.al-jamal@qub.ac.uk.

Acta Biomater ; 134: 559-575, 2021 10 15.

Article en En | MEDLINE | ID: mdl-34274531

Asunto(s)

Profármacos; Neoplasias de la Próstata; Animales; Humanos; Masculino; Ratones; Antígeno Prostático Específico; Neoplasias de la Próstata/tratamiento farmacológico; Células U937

Palabras clave

Advanced prostate cancer; Bioinspired nanovesicles; Cancer therapy; Doxorubicin-PSA prodrug; Dually targeted nanoparticles; Prostate-specific membrane antigen (PSMA)

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Profármacos Límite: Animals / Humans / Male Idioma: En Revista: Acta Biomater Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google